Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:4041374rdf:typepubmed:Citationlld:pubmed
pubmed-article:4041374lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:4041374lifeskim:mentionsumls-concept:C0015965lld:lifeskim
pubmed-article:4041374lifeskim:mentionsumls-concept:C0086024lld:lifeskim
pubmed-article:4041374lifeskim:mentionsumls-concept:C0439659lld:lifeskim
pubmed-article:4041374lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:4041374lifeskim:mentionsumls-concept:C0205227lld:lifeskim
pubmed-article:4041374pubmed:issue2lld:pubmed
pubmed-article:4041374pubmed:dateCreated1985-11-19lld:pubmed
pubmed-article:4041374pubmed:abstractTextThe cobalamin content of placenta, maternal and fetal sera was assayed by methods which measure microbiologically-active and microbiologically-inactive cobalamins. Only microbiologically-active cobalamins were present in the placenta but both types were present in both maternal and fetal circulations. We conclude that only microbiologically-active cobalamins cross the placenta and that the microbiologically inactive cobalamins in the fetus must arise by metabolism in situ.lld:pubmed
pubmed-article:4041374pubmed:languageenglld:pubmed
pubmed-article:4041374pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4041374pubmed:citationSubsetIMlld:pubmed
pubmed-article:4041374pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4041374pubmed:statusMEDLINElld:pubmed
pubmed-article:4041374pubmed:monthOctlld:pubmed
pubmed-article:4041374pubmed:issn0007-1048lld:pubmed
pubmed-article:4041374pubmed:authorpubmed-author:LandonMMlld:pubmed
pubmed-article:4041374pubmed:authorpubmed-author:MuirMMlld:pubmed
pubmed-article:4041374pubmed:issnTypePrintlld:pubmed
pubmed-article:4041374pubmed:volume61lld:pubmed
pubmed-article:4041374pubmed:ownerNLMlld:pubmed
pubmed-article:4041374pubmed:authorsCompleteYlld:pubmed
pubmed-article:4041374pubmed:pagination303-6lld:pubmed
pubmed-article:4041374pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:4041374pubmed:meshHeadingpubmed-meshheading:4041374-...lld:pubmed
pubmed-article:4041374pubmed:meshHeadingpubmed-meshheading:4041374-...lld:pubmed
pubmed-article:4041374pubmed:meshHeadingpubmed-meshheading:4041374-...lld:pubmed
pubmed-article:4041374pubmed:meshHeadingpubmed-meshheading:4041374-...lld:pubmed
pubmed-article:4041374pubmed:meshHeadingpubmed-meshheading:4041374-...lld:pubmed
pubmed-article:4041374pubmed:meshHeadingpubmed-meshheading:4041374-...lld:pubmed
pubmed-article:4041374pubmed:meshHeadingpubmed-meshheading:4041374-...lld:pubmed
pubmed-article:4041374pubmed:meshHeadingpubmed-meshheading:4041374-...lld:pubmed
pubmed-article:4041374pubmed:year1985lld:pubmed
pubmed-article:4041374pubmed:articleTitleEndogenous origin of microbiologically-inactive cobalamins (cobalamin analogues) in the human fetus.lld:pubmed
pubmed-article:4041374pubmed:publicationTypeJournal Articlelld:pubmed